289 related articles for article (PubMed ID: 9497785)
21. A perspective on xenograft rejection and accommodation.
Platt JL
Immunol Rev; 1994 Oct; 141():127-49. PubMed ID: 7868152
[TBL] [Abstract][Full Text] [Related]
22. Transgenic pigs for xenotransplantation: selection of promoter sequences for reliable transgene expression.
Aigner B; Klymiuk N; Wolf E
Curr Opin Organ Transplant; 2010 Apr; 15(2):201-6. PubMed ID: 20061949
[TBL] [Abstract][Full Text] [Related]
23. Role of complement in xenotransplantation.
Mollnes TE; Fiane AE
Allergy; 2002; 57 Suppl 72():75-8. PubMed ID: 12144560
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation.
Chen RH; Kadner A; Mitchell RN; Adams DH
J Surg Res; 2000 May; 90(2):119-25. PubMed ID: 10792951
[TBL] [Abstract][Full Text] [Related]
25. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
Malassagne B; Calmus Y; Houssin D; Weill B
Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
[TBL] [Abstract][Full Text] [Related]
26. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.
Fodor WL; Williams BL; Matis LA; Madri JA; Rollins SA; Knight JW; Velander W; Squinto SP
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11153-7. PubMed ID: 7526391
[TBL] [Abstract][Full Text] [Related]
27. Preventing T cell rejection of pig xenografts.
Higginbotham L; Ford ML; Newell KA; Adams AB
Int J Surg; 2015 Nov; 23(Pt B):285-290. PubMed ID: 26306770
[TBL] [Abstract][Full Text] [Related]
28. Loss of ecto-5'nucleotidase from porcine endothelial cells after exposure to human blood: Implications for xenotransplantation.
Khalpey Z; Yuen AH; Kalsi KK; Kochan Z; Karbowska J; Slominska EM; Forni M; Macherini M; Bacci ML; Batten P; Lavitrano M; Yacoub MH; Smolenski RT
Biochim Biophys Acta; 2005 Jun; 1741(1-2):191-8. PubMed ID: 15955461
[TBL] [Abstract][Full Text] [Related]
29. Human cell-mediated rejection of porcine xenografts in an immunodeficient mouse model.
Sawada T; DellaPelle PA; Seebach JD; Sachs DH; Colvin RB; Iacomini J
Transplantation; 1997 May; 63(9):1331-8. PubMed ID: 9158029
[TBL] [Abstract][Full Text] [Related]
30. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts.
Kaplon RJ; Michler RE; Xu H; Kwiatkowski PA; Edwards NM; Platt JL
Transplantation; 1995 Jan; 59(1):1-6. PubMed ID: 7839407
[TBL] [Abstract][Full Text] [Related]
31. New concepts of immune modulation in xenotransplantation.
Satyananda V; Hara H; Ezzelarab MB; Phelps C; Ayares D; Cooper DK
Transplantation; 2013 Dec; 96(11):937-45. PubMed ID: 23851935
[TBL] [Abstract][Full Text] [Related]
32. Recent strategies to overcome the hyperacute rejection in pig to human xenotransplantation.
Igaz P
Yale J Biol Med; 2001; 74(5):329-40. PubMed ID: 11769339
[TBL] [Abstract][Full Text] [Related]
33. Progress in xenotransplantation.
Cozzi E; Masroor S; Soin B; Vial C; White DJ
Clin Nephrol; 2000 Apr; 53(4):suppl 13-8. PubMed ID: 10809429
[TBL] [Abstract][Full Text] [Related]
34. Serum anti-pig antibodies as potential indicators of acute humoral xenograft rejection in pig-to-cynomolgus monkey kidney transplantation.
Richards AC; Davies HF; McLaughlin ML; Copeman LS; Holmes BJ; Dos Santos Cruz G; Bycroft S; Chavez G; White DJ; Schuurman HJ; Cozzi E
Transplantation; 2002 Mar; 73(6):881-9. PubMed ID: 11923687
[TBL] [Abstract][Full Text] [Related]
35. [Mechanisms of xenotransplant rejection].
Candinas D; Seebach JD
Zentralbl Chir; 1999; 124(7):591-9. PubMed ID: 10474871
[TBL] [Abstract][Full Text] [Related]
36. A human CD46 transgenic pig model system for the study of discordant xenotransplantation.
Diamond LE; Quinn CM; Martin MJ; Lawson J; Platt JL; Logan JS
Transplantation; 2001 Jan; 71(1):132-42. PubMed ID: 11211178
[TBL] [Abstract][Full Text] [Related]
37. Xenotransplantation-current status and future perspectives.
Cozzi E; Bosio E; Seveso M; Vadori M; Ancona E
Br Med Bull; 2005; 75-76():99-114. PubMed ID: 16723634
[TBL] [Abstract][Full Text] [Related]
38. CD4+CD25
Singh AK; Chan JL; Seavey CN; Corcoran PC; Hoyt RF; Lewis BGT; Thomas ML; Ayares DL; Horvath KA; Mohiuddin MM
Xenotransplantation; 2018 Mar; 25(2):e12379. PubMed ID: 29250828
[TBL] [Abstract][Full Text] [Related]
39. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
[TBL] [Abstract][Full Text] [Related]
40. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses.
Denner J; Schuurman HJ; Patience C
Xenotransplantation; 2009; 16(4):239-48. PubMed ID: 19799764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
